REPORT ON JAK2 PREVALENCE AMONG MPD PATIENTS IN INDIA

  • MPNRF | May 3, 2021

    October 2010

    The Indian Journal of Medical Research recently published an article reporting the prevalence of the JAK2 mutation among polycythemia vera, essential thrombocythemia and myelofibrosis patients at a clinic in northern India. The JAK2 mutation, a gene marker for the Myeloproliferative disorders, was discovered in 2005.

    To read the full article click here.